Answers are grounded in this paper and cite their sources.
A protein-cleaving catalyst specific for a disease-related protein can be used as a catalytic drug. As the first protein-cleaving catalyst selective for a protein substrate, a catalyst for myoglobin was designed by attaching Cu(II) or Co(III) complex of cyclen to a binding site searched by a combinatorial method using peptide nucleic acid monomers as building units. [reaction: see text]
No takes yet. Share an insight, caveat, or question.
Jeon et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: